Swiss Pharmaceuticals & Biotech Profitable Climbers

Newron Pharmaceuticals

Market Cap: CHF 152.3m

A biopharmaceutical company, discovers and develops novel therapies for patients with diseases of the central and peripheral nervous system in Italy and the United States.

SKAN Group

Market Cap: CHF 1.5b

Provides isolators, cleanroom devices, and decontamination processes for pharmaceutical and chemical industries in Europe, the Americas, Asia, and internationally.

Cosmo Pharmaceuticals

Market Cap: CHF 924.5m

Focuses on the development and commercialization products for gastroenterology, dermatology, and healthtech worldwide.

Sandoz Group

Market Cap: CHF 21.6b

Develops, manufactures, and markets generic pharmaceuticals and biosimilars worldwide.

Galderma Group

Market Cap: CHF 32.1b

Operates as a dermatology company worldwide.

Lonza Group

Market Cap: CHF 40.0b

Supplies various products and services for pharmaceutical, biotech, and nutrition markets in Europe, North and Central America, Latin America, Asia, Australia, New Zealand, and internationally.